Literature DB >> 34060125

Treatment of pruritus with botulinum toxin in a pediatric patient with Fox-Fordyce disease.

Skylar Klager1, Monique Gupta Kumar2.   

Abstract

Fox-Fordyce disease is a chronic pruritic disorder of apocrine sweat glands that is often associated with significantly decreased quality of life. With no definitive cure, affected patients are often treated with topical corticosteroids as first-line therapy, but evidence for treatment of refractory cases is limited. We present an adolescent with Fox-Fordyce disease successfully treated for symptomatic relief with botulinum toxin type A injections. While previously reported in an adult patient, we detail the efficacy of this therapy in a pediatric patient.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Fox-Fordyce; botulinum toxin type A

Year:  2021        PMID: 34060125     DOI: 10.1111/pde.14552

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  3 in total

1.  Refractory pruritic Fox-Fordyce disease successfully treated with botulinum toxin type A.

Authors:  Meshal Mohammad Alhameedy; Muhammad Usman Tariq
Journal:  Int J Womens Dermatol       Date:  2022-08-11

Review 2.  Treatment Options for Troublesome Itch.

Authors:  Sumika Toyama; Mitsutoshi Tominaga; Kenji Takamori
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-19

Review 3.  Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects.

Authors:  Hao-Jui Weng; Quoc Thao Trang Pham; Chia-Wei Chang; Tsen-Fang Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.